188 related articles for article (PubMed ID: 25894142)
1. Hepatitis B- and hepatitis D-virus-related liver transplant: single-center data.
Öcal S; Korkmaz M; Harmancı Ö; Ensaroğlu F; Akdur A; Selçuk H; Moray G; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():133-8. PubMed ID: 25894142
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Hepatitis B Virus Infection After Living-Donor Liver Transplant: A Single-center Experience Over 20 Years.
Nafady-Hego H; Elgendy H; Nafady A; Uemoto S
Exp Clin Transplant; 2016 Apr; 14(2):207-14. PubMed ID: 26867537
[TBL] [Abstract][Full Text] [Related]
3. A new scheme with infusion of hepatitis B immunoglobulin combined with entecavir for prophylaxis of hepatitis B virus recurrence among liver transplant recipients.
Chen G; Liu H; Hu ZQ; Bai JH; Liu QY; Zhao YP; Gan XM; Wang F; Wang DD; Ma LJ; Li L
Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):901-6. PubMed ID: 26011237
[TBL] [Abstract][Full Text] [Related]
4. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation.
Fung J; Cheung C; Chan SC; Yuen MF; Chok KS; Sharr W; Dai WC; Chan AC; Cheung TT; Tsang S; Lam B; Lai CL; Lo CM
Gastroenterology; 2011 Oct; 141(4):1212-9. PubMed ID: 21762659
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of renal transplant recipients with chronic hepatitis B infection-impact of antiviral treatments.
Yap DY; Tang CS; Yung S; Choy BY; Yuen MF; Chan TM
Transplantation; 2010 Aug; 90(3):325-30. PubMed ID: 20562676
[TBL] [Abstract][Full Text] [Related]
6. Successful withdrawal of antiviral treatment in kidney transplant recipients with chronic hepatitis B viral infection.
Cho JH; Lim JH; Park GY; Kim JS; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD
Transpl Infect Dis; 2014 Apr; 16(2):295-303. PubMed ID: 24628837
[TBL] [Abstract][Full Text] [Related]
7. Management of hepatitis B virus infection after liver transplantation.
Jiménez-Pérez M; González-Grande R; Mostazo Torres J; González Arjona C; Rando-Muñoz FJ
World J Gastroenterol; 2015 Nov; 21(42):12083-90. PubMed ID: 26576093
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcome of acute and chronic hepatitis delta over time: a long-term follow-up study.
Buti M; Homs M; Rodriguez-Frias F; Funalleras G; Jardí R; Sauleda S; Tabernero D; Schaper M; Esteban R
J Viral Hepat; 2011 Jun; 18(6):434-42. PubMed ID: 20546496
[TBL] [Abstract][Full Text] [Related]
9. Liver transplantation in delta virus infection.
Roche B; Samuel D
Semin Liver Dis; 2012 Aug; 32(3):245-55. PubMed ID: 22932973
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
11. Allografts positive for hepatitis B surface antigen in liver transplant for disease related to hepatitis B virus.
Ju W; Chen M; Guo Z; Wang D; Zhu X; Huang J; He X
Exp Clin Transplant; 2013 Jun; 11(3):245-9. PubMed ID: 23176583
[TBL] [Abstract][Full Text] [Related]
12. Oral nucleoside/nucleotide analogs without hepatitis B immune globulin after liver transplantation for hepatitis B.
Fung J; Chan SC; Cheung C; Yuen MF; Chok KS; Sharr W; Chan AC; Cheung TT; Seto WK; Fan ST; Lai CL; Lo CM
Am J Gastroenterol; 2013 Jun; 108(6):942-8. PubMed ID: 23629601
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis B: Evolution over two decades.
Yuen MF; Lai CL
J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():138-43. PubMed ID: 21199525
[TBL] [Abstract][Full Text] [Related]
14. A case of cerebral tuberculosis after liver transplant and literature review.
Tunca MZ; Yılmaz Akçay E; Moray G; Özen Ö; Özdemir BH
Exp Clin Transplant; 2014 Mar; 12 Suppl 1():117-9. PubMed ID: 24635807
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of hepatitis B-related liver cirrhosis in the era of oral nucleos(t)ide analog antiviral agents.
Kim CH; Um SH; Seo YS; Jung JY; Kim JD; Yim HJ; Keum B; Kim YS; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2012 Oct; 27(10):1589-95. PubMed ID: 22554121
[TBL] [Abstract][Full Text] [Related]
16. Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine.
Lim YS; Han S; Heo NY; Shim JH; Lee HC; Suh DJ
Gastroenterology; 2014 Jul; 147(1):152-61. PubMed ID: 24583062
[TBL] [Abstract][Full Text] [Related]
17. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.
Squadrito G; Cacciola I; Alibrandi A; Pollicino T; Raimondo G
J Hepatol; 2013 Oct; 59(4):696-700. PubMed ID: 23751755
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of liver transplanted HIV/hepatitis B virus coinfected patients: perfect control of hepatitis B virus replication and absence of mitochondrial toxicity.
Tateo M; Roque-Afonso AM; Antonini TM; Medja F; Lombes A; Jardel C; Teicher E; Sebagh M; Roche B; Castaing D; Samuel D; Duclos-Vallee JC
AIDS; 2009 Jun; 23(9):1069-76. PubMed ID: 19417577
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization for hepatitis B virus-associated hepatocellular carcinoma: improved survival after concomitant treatment with nucleoside analogues.
Toyoda H; Kumada T; Tada T; Sone Y; Fujimori M
J Vasc Interv Radiol; 2012 Mar; 23(3):317-22.e1. PubMed ID: 22265248
[TBL] [Abstract][Full Text] [Related]
20. Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis.
Wong GL; Chan HL; Mak CW; Lee SK; Ip ZM; Lam AT; Iu HW; Leung JM; Lai JW; Lo AO; Chan HY; Wong VW
Hepatology; 2013 Nov; 58(5):1537-47. PubMed ID: 23389810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
